Axsome Therapeutics, Inc. (NASDAQ:AXSM) has 388 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 4,164,818 | -15,828 | -0.38% | $760,662,360.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,913,543 | 122,614 | 3.23% | $714,769,493.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,912,844 | -699 | -0.02% | $661,348,893.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Dec, 2025 | 2,058,170 | 2,058,170 | 0.00% | $347,871,893.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,937,752 | 1,937,752 | 0.00% | $327,518,843.00 |
| FMR LLC | 31 Dec, 2025 | 1,566,995 | 385,373 | 32.61% | $264,853,495.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Dec, 2025 | 1,317,059 | 1,317,059 | 0.00% | $222,610.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,297,678 | 24,184 | 1.90% | $219,333,537.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,273,494 | 282,937 | 28.56% | $232,590,944.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 1,221,656 | -112,904 | -8.46% | $223,123,252.00 |
| FMR LLC | 31 Dec, 2025 | 1,181,622 | 253,739 | 27.35% | $215,811,444.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,162,981 | 152,732 | 15.12% | $196,601,071.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 1,150,000 | 250,000 | 27.78% | $210,036,000.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 1,145,306 | -76,350 | -6.25% | $193,579,622.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 1,100,000 | -50,000 | -4.35% | $185,922,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,010,249 | 12,549 | 1.26% | $184,544,219.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Dec, 2025 | 989,447 | 989,447 | 0.00% | $180,713,000.00 |
| State Street Corp | 31 Dec, 2025 | 986,809 | 28,659 | 2.99% | $166,790,457.00 |
| State Street Corp | 31 Dec, 2025 | 958,150 | 15,190 | 1.61% | $174,996,516.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 888,001 | -230,882 | -20.64% | $162,184,503.00 |